Mesothelioma

People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

US scientists analysing tumour samples from patients with mesothelioma have mapped out the gene faults associated with the disease in unprecedented detail.

In 1978 Professor Julian Peto published a scientific paper that influenced many lives, by helping to usher in an era free from asbestos.

A new survey has highlighted the need for Britons to improve their awareness of asbestos.

One in 17 British carpenters born in the 1940s will die of mesothelioma – a cancer of the lining of the lung caused by asbestos – according to new research* published in the British Journal of Cancer.

“Nanotechnology” – technology on a microscopic scale – has been one of the scientific buzzwords bandied about most often in…

Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this weekїs British Journal of Cancer1.